News & EventsSTERNA BIOLOGICALS
_____
2015
Company News 2015
-
sterna biologicals announces publication of SB010 Phase IIa results in the New England Journal of Medicine
Marburg, Germany, 17 May 2015
- SB010 Phase IIa proof-of-concept results published in the New England Journal of Medicine
- SB010 Phase I programme results published in the Journal of Allergy and Clinical Immunology
- SB010 development programme comprising four completed clinical trials demonstrates excellent safety profile combined with efficacy comparable to monoclonal antibodies